+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dendritic Cell Cancer Vaccine Market - Global Forecast 2025-2030- Product Image
Dendritic Cell Cancer Vaccine Market - Global Forecast 2025-2030- Product Image
Sale

Dendritic Cell Cancer Vaccine Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5967966
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The dendritic cell cancer vaccine market is undergoing rapid transformation as immunotherapy redefines cancer care. Senior executives navigating this space need reliable insights into emerging technologies, shifting regulatory frameworks, and the evolving competitive landscape. In-depth market intelligence supports informed decisions that can optimize investment, drive innovation, and deliver measurable impact.

Market Snapshot: Dendritic Cell Cancer Vaccine Market Overview

The dendritic cell cancer vaccine market grew from USD 392.59 million in 2024 to USD 444.97 million in 2025, reflecting a compound annual growth rate (CAGR) of 13.23%. This momentum is expected to propel the sector to USD 827.59 million by 2030. Market growth is fueled by ongoing innovation in immuno-oncology, steady investment from industry leaders, and a maturing regulatory environment that is increasingly supportive of advanced therapies.

Scope & Segmentation: Comprehensive Market Coverage

This report delivers a thorough examination of all core segments and drivers that influence commercialization and adoption of dendritic cell cancer vaccine solutions, including:

  • Vaccine Type: Analysis includes allogeneic and autologous vaccines, each with their unique manufacturing and clinical profiles.
  • Cancer Indications: Coverage of hematological malignancies such as leukemia and lymphoma, and solid tumors including breast, lung, and melanoma.
  • Administration Routes: Insights into intradermal, intravenous, and subcutaneous injection strategies, considering the implications of manual and prefilled delivery systems.
  • End Users: Review of operational impact for hospitals, research institutes, and specialty clinics as stakeholders in vaccine deployment.
  • Technology Platforms: Comparison between ex vivo pulsing and in vivo targeting approaches, highlighting scalability and customization opportunities.
  • Therapy Stages: Details of clinical development stages, from early-phase trials to commercial rollout.
  • Distribution Channels: Evaluation of pathways to patient access, including hospital pharmacies, online platforms, and specialty centers.
  • Regional Analysis: Strategic review encompassing the Americas, Europe, Middle East & Africa, and Asia-Pacific, with further granularity across major countries and subregions.
  • Competitive Landscape: Recent developments associated with major industry participants such as Northwest Biotherapeutics, Immunicum AB, Cell Medica Ltd., and other leading pharmaceutical organizations.

Dendritic Cell Cancer Vaccine Market: Key Takeaways

  • Pivotal technological advances are improving antigen delivery precision and enabling large-scale, standardized production to meet rising clinical demand.
  • Strategic collaborations and M&A activity are reshaping competition, with industry leaders expanding early clinical pipelines and proprietary platforms to secure market share.
  • Personalized medicine approaches, powered by biomarker-driven patient stratification, are set to improve therapy outcomes and ensure efficient trial success.
  • Healthcare infrastructure, regulatory harmonization, and reimbursement models continue to influence uptake across diverse regions, requiring localized go-to-market strategies.
  • Cold chain logistics and scalable manufacturing platforms are now essential for supporting regional market expansion and mitigating operational disruptions.

Tariff Impact on Supply Chain and Pricing

Recent U.S. tariff adjustments on key vaccine inputs—including cell culture media, cytokines, and laboratory equipment—have introduced cost pressures across supply chains. Developers are responding by renegotiating procurement contracts, optimizing supply routes, and exploring regional sourcing alternatives to maintain competitive pricing and scalable production. These measures help stabilize patient access, minimize volatility, and sustain the growth trajectory in a highly regulated environment.

Methodology & Data Sources

This report leverages a multi-phase research methodology. Primary sources include interviews with immuno-oncology leaders, supply chain specialists, and regulatory experts. Extensive secondary research spans peer-reviewed literature, market intelligence databases, filings, and trade publications to ensure robust, triangulated findings relevant to technology adoption, therapy progression, and distribution channel evolution.

Why This Report Matters: Actionable Insights for Senior Leaders

  • Support rapid decision-making with up-to-date, segmented analysis aligned to current industry and regulatory trends.
  • Develop targeted strategies by understanding core growth drivers, operational risks, and competitive innovations across major geographies.
  • Capitalize on investment and partnership opportunities by accessing reliable intelligence on evolving supply chains, tariff impacts, and regional uptake.

Conclusion

The dendritic cell cancer vaccine market is poised for continued advancement, driven by innovation in manufacturing and therapy delivery. With actionable, data-driven insights, industry leaders can confidently navigate complexity and drive effective growth strategies in the expanding immunotherapy landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of personalized neoantigen-loaded dendritic cell vaccines with PD-1 inhibitors to improve anti-tumor efficacy
5.2. Development of off-the-shelf allogeneic dendritic cell vaccines to lower manufacturing costs and accelerate market access
5.3. Implementation of automated GMP-compliant bioreactor platforms for scalable dendritic cell vaccine production and consistency
5.4. Use of mRNA-encoded antigens in dendritic cell vaccines for enhanced T-cell activation and broader immune responses
5.5. Clinical trial data highlighting extended survival in melanoma patients receiving dendritic cell vaccines combined with checkpoint blockade
5.6. Incorporation of nanocarrier systems in dendritic cell vaccine formulations for targeted delivery and improved immunogenicity
5.7. Regulatory pathway optimizations for dendritic cell-based cancer therapies to streamline approval and commercialization timelines
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Dendritic Cell Cancer Vaccine Market, by Vaccine Type
8.1. Introduction
8.2. Allogeneic
8.2.1. DC Cell Lines
8.2.2. DC In Vitro Maturation
8.3. Autologous
8.3.1. DC Cell Lines
8.3.2. DC In Vitro Maturation
9. Dendritic Cell Cancer Vaccine Market, by Cancer Type
9.1. Introduction
9.2. Hematological Malignancy
9.2.1. Leukemia
9.2.2. Lymphoma
9.3. Solid Tumor
9.3.1. Breast Cancer
9.3.2. Lung Cancer
9.3.3. Melanoma
10. Dendritic Cell Cancer Vaccine Market, by Administration Route
10.1. Introduction
10.2. Intradermal Injection
10.2.1. Manual Injection
10.2.2. Prefilled Syringe
10.3. Intravenous Injection
10.3.1. Manual Injection
10.3.2. Prefilled Syringe
10.4. Subcutaneous Injection
10.4.1. Manual Injection
10.4.2. Prefilled Syringe
11. Dendritic Cell Cancer Vaccine Market, by End User
11.1. Introduction
11.2. Hospital
11.3. Research Institute
11.4. Specialty Clinic
12. Dendritic Cell Cancer Vaccine Market, by Technology Platform
12.1. Introduction
12.2. Ex Vivo Pulsing
12.3. In Vivo Targeting
13. Dendritic Cell Cancer Vaccine Market, by Therapy Stage
13.1. Introduction
13.2. Clinical Stage
13.2.1. Phase I
13.2.2. Phase II
13.2.3. Phase III
13.3. Commercial Stage
14. Dendritic Cell Cancer Vaccine Market, by Distribution Channel
14.1. Introduction
14.2. Hospital Pharmacy
14.3. Online Pharmacy
14.4. Specialty Center
15. Americas Dendritic Cell Cancer Vaccine Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Dendritic Cell Cancer Vaccine Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Dendritic Cell Cancer Vaccine Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Northwest Biotherapeutics, Inc.
18.3.2. Immunicum AB
18.3.3. Cell Medica Ltd.
18.3.4. Dendreon Pharmaceuticals LLC
18.3.5. Prima BioMed Ltd.
18.3.6. F. Hoffmann-La Roche Ltd.
18.3.7. GlaxoSmithKline plc
18.3.8. Merck & Co., Inc.
18.3.9. Pfizer Inc.
18.3.10. Novartis AG
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. DENDRITIC CELL CANCER VACCINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY THERAPY STAGE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY THERAPY STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. DENDRITIC CELL CANCER VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. DENDRITIC CELL CANCER VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. DENDRITIC CELL CANCER VACCINE MARKET: RESEARCHAI
FIGURE 30. DENDRITIC CELL CANCER VACCINE MARKET: RESEARCHSTATISTICS
FIGURE 31. DENDRITIC CELL CANCER VACCINE MARKET: RESEARCHCONTACTS
FIGURE 32. DENDRITIC CELL CANCER VACCINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DENDRITIC CELL CANCER VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ALLOGENEIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ALLOGENEIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY DC CELL LINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY DC CELL LINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY DC IN VITRO MATURATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY DC IN VITRO MATURATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ALLOGENEIC, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ALLOGENEIC, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY DC CELL LINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY DC CELL LINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY DC IN VITRO MATURATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY DC IN VITRO MATURATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY AUTOLOGOUS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY AUTOLOGOUS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY HEMATOLOGICAL MALIGNANCY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY HEMATOLOGICAL MALIGNANCY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY LYMPHOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY HEMATOLOGICAL MALIGNANCY, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY HEMATOLOGICAL MALIGNANCY, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SOLID TUMOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SOLID TUMOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY MELANOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY MELANOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SOLID TUMOR, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SOLID TUMOR, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRADERMAL INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRADERMAL INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY MANUAL INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY MANUAL INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRADERMAL INJECTION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRADERMAL INJECTION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRAVENOUS INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRAVENOUS INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY MANUAL INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY MANUAL INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRAVENOUS INJECTION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRAVENOUS INJECTION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SUBCUTANEOUS INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SUBCUTANEOUS INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY MANUAL INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY MANUAL INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SUBCUTANEOUS INJECTION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SUBCUTANEOUS INJECTION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY EX VIVO PULSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY EX VIVO PULSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY IN VIVO TARGETING, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY IN VIVO TARGETING, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY THERAPY STAGE, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY THERAPY STAGE, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CLINICAL STAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CLINICAL STAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CLINICAL STAGE, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CLINICAL STAGE, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY COMMERCIAL STAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY COMMERCIAL STAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SPECIALTY CENTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SPECIALTY CENTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ALLOGENEIC, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ALLOGENEIC, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY AUTOLOGOUS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY AUTOLOGOUS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY HEMATOLOGICAL MALIGNANCY, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY HEMATOLOGICAL MALIGNANCY, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SOLID TUMOR, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SOLID TUMOR, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRADERMAL INJECTION, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRADERMAL INJECTION, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRAVENOUS INJECTION, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRAVENOUS INJECTION, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SUBCUTANEOUS INJECTION, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SUBCUTANEOUS INJECTION, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY THERAPY STAGE, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY THERAPY STAGE, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CLINICAL STAGE, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CLINICAL STAGE, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ALLOGENEIC, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ALLOGENEIC, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY AUTOLOGOUS, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY AUTOLOGOUS, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY HEMATOLOGICAL MALIGNANCY, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY HEMATOLOGICAL MALIGNANCY, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SOLID TUMOR, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SOLID TUMOR, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRADERMAL INJECTION, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRADERMAL INJECTION, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRAVENOUS INJECTION, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRAVENOUS INJECTION, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SUBCUTANEOUS INJECTION, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SUBCUTANEOUS INJECTION, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY THERAPY STAGE, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY THERAPY STAGE, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CLINICAL STAGE, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CLINICAL STAGE, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 173. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 174. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 175. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ALLOGENEIC, 2018-2024 (USD MILLION)
TABLE 176. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ALLOGENEIC, 2025-2030 (USD MILLION)
TABLE 177. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY AUTOLOGOUS, 2018-2024 (USD MILLION)
TABLE 178. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY AUTOLOGOUS, 2025-2030 (USD MILLION)
TABLE 179. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 180. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 181. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY HEMATOLOGICAL MALIGNANCY, 2018-2024 (USD MILLION)
TABLE 182. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY HEMATOLOGICAL MALIGNANCY, 2025-2030 (USD MILLION)
TABLE 183. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SOLID TUMOR, 2018-2024 (USD MILLION)
TABLE 184. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SOLID TUMOR, 2025-2030 (USD MILLION)
TABLE 185. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 186. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 187. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRADERMAL INJECTION, 2018-2024 (USD MILLION)
TABLE 188. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRADERMAL INJECTION, 2025-2030 (USD MILLION)
TABLE 189. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRAVENOUS INJECTION, 2018-2024 (USD MILLION)
TABLE 190. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRAVENOUS INJECTION, 2025-2030 (USD MILLION)
TABLE 191. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SUBCUTANEOUS INJECTION, 2018-2024 (USD MILLION)
TABLE 192. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SUBCUTANEOUS INJECTION, 2025-2030 (USD MILLION)
TABLE 193. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 196. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 197. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY THERAPY STAGE, 2018-2024 (USD MILLION)
TABLE 198. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY THERAPY STAGE, 2025-2030 (USD MILLION)
TABLE 199. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CLINICAL STAGE, 2018-2024 (USD MILLION)
TABLE 200. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CLINICAL STAGE, 2025-2030 (USD MILLION)
TABLE 201. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. CANADA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 204. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 205. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ALLOGENEIC, 2018-2024 (USD MILLION)
TABLE 206. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ALLOGENEIC, 2025-2030 (USD MILLION)
TABLE 207. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY AUTOLOGOUS, 2018-2024 (USD MILLION)
TABLE 208. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY AUTOLOGOUS, 2025-2030 (USD MILLION)
TABLE 209. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 210. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 211. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY HEMATOLOGICAL MALIGNANCY, 2018-2024 (USD MILLION)
TABLE 212. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY HEMATOLOGICAL MALIGNANCY, 2025-2030 (USD MILLION)
TABLE 213. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SOLID TUMOR, 2018-2024 (USD MILLION)
TABLE 214. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SOLID TUMOR, 2025-2030 (USD MILLION)
TABLE 215. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 216. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 217. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRADERMAL INJECTION, 2018-2024 (USD MILLION)
TABLE 218. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRADERMAL INJECTION, 2025-2030 (USD MILLION)
TABLE 219. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRAVENOUS INJECTION, 2018-2024 (USD MILLION)
TABLE 220. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRAVENOUS INJECTION, 2025-2030 (USD MILLION)
TABLE 221. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SUBCUTANEOUS INJECTION, 2018-2024 (USD MILLION)
TABLE 222. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SUBCUTANEOUS INJECTION, 2025-2030 (USD MILLION)
TABLE 223. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 226. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 227. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY THERAPY STAGE, 2018-2024 (USD MILLION)
TABLE 228. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY THERAPY STAGE, 2025-2030 (USD MILLION)
TABLE 229. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CLINICAL STAGE, 2018-2024 (USD MILLION)
TABLE 230. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CLINICAL STAGE, 2025-2030 (USD MILLION)
TABLE 231. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. MEXICO DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ALLOGENEIC, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ALLOGENEIC, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY AUTOLOGOUS, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY AUTOLOGOUS, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY HEMATOLOGICAL MALIGNANCY, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY HEMATOLOGICAL MALIGNANCY, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SOLID TUMOR, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SOLID TUMOR, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRADERMAL INJECTION, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRADERMAL INJECTION, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRAVENOUS INJECTION, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRAVENOUS INJECTION, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SUBCUTANEOUS INJECTION, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SUBCUTANEOUS INJECTION, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY THERAPY STAGE, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY THERAPY STAGE, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CLINICAL STAGE, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CLINICAL STAGE, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ALLOGENEIC, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ALLOGENEIC, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY AUTOLOGOUS, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY AUTOLOGOUS, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY HEMATOLOGICAL MALIGNANCY, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY HEMATOLOGICAL MALIGNANCY, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SOLID TUMOR, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SOLID TUMOR, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRADERMAL INJECTION, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRADERMAL INJECTION, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRAVENOUS INJECTION, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY INTRAVENOUS INJECTION, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SUBCUTANEOUS INJECTION, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY SUBCUTANEOUS INJECTION, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY THERAPY STAGE, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY THERAPY STAGE, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CLINICAL STAGE, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CLINICAL STAGE, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ALLOGENEIC, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY ALLOGENEIC, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY AUTOLOGOUS, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY AUTOLOGOUS, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA DENDRITIC CELL CANCER VACCINE MARKET SIZE, BY HEMATOLOGICAL MALIGNANCY, 2018-2024 (USD MILLION)
TABLE 302.

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Dendritic Cell Cancer Vaccine market report include:
  • Northwest Biotherapeutics, Inc.
  • Immunicum AB
  • Cell Medica Ltd.
  • Dendreon Pharmaceuticals LLC
  • Prima BioMed Ltd.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Novartis AG

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 444.97 Million
Forecasted Market Value ( USD ) by 2030 $ 827.59 Million
Compound Annual Growth Rate13.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Dendritic Cell Cancer Vaccines - Global Strategic Business Report - Product Image

Dendritic Cell Cancer Vaccines - Global Strategic Business Report

  • Report
  • 142 Pages
  • Global
From
Dendritic Cell Cancer Vaccine Market Report 2025 - Product Image

Dendritic Cell Cancer Vaccine Market Report 2025

  • Report
  • 200 Pages
  • Global
From
2025 Global Forecast for Dendritic Cell Cancer Vaccine Immunotherapy Market (2026-2031 Outlook)-High Tech Outlook Report - Product Image

2025 Global Forecast for Dendritic Cell Cancer Vaccine Immunotherapy Market (2026-2031 Outlook)-High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Cancer Vaccines Market - Global Forecast 2025-2030 - Product Image

Cancer Vaccines Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Personalized Cancer Vaccine Market Size, Share & Trends Analysis Report by Type (Dendritic Cell, RNA-based (MRNA), Neoantigen-based), Technology (Cell-based, MRNA PCV), Distribution Channel, and Region with Growth Forecasts, 2025-2030 - Product Image

Personalized Cancer Vaccine Market Size, Share & Trends Analysis Report by Type (Dendritic Cell, RNA-based (MRNA), Neoantigen-based), Technology (Cell-based, MRNA PCV), Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • 195 Pages
  • Global
From

About the Market

The Dendritic Cell Cancer Vaccine is a type of cancer vaccine that uses a patient's own dendritic cells to stimulate an immune response against cancer cells. Dendritic cells are a type of white blood cell that can recognize and respond to foreign substances in the body. The vaccine works by extracting dendritic cells from the patient's blood, loading them with antigens from the patient's cancer cells, and then reintroducing them into the patient's body. This stimulates the patient's immune system to recognize and attack the cancer cells. The Dendritic Cell Cancer Vaccine market is a rapidly growing segment of the cancer vaccine market. It is a promising approach to cancer treatment, as it is personalized to the patient and has the potential to be more effective than traditional cancer treatments. Companies in the Dendritic Cell Cancer Vaccine market include Immunovative Therapies, Inc., ImmunoCellular Therapeutics, Ltd., and OncoImmune, Inc. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.